CompletedNot Applicable

Effect of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg in Septic Shock Patients

Indonesia44 participantsStarted 2019-11-14

Plain-language summary

A scientific research to prove the safety and effectiveness of TVS 0 - 4 mmHg as a target of resuscitation using furosemide, to improve Perfused Vessel Density (PVD) \> 25 mm / mm2, AKI stage (based on KDIGO criteria), CI \> 2.5 cc / min / m2 , prevent the incidence of intubation, reduce the duration of ventilator use \<120 hours and reduce the length of ICU stay in patients with septic shock after resuscitation

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Septic shock patients who meet the diagnosis criteria for quick SOFA and KDIGO 1 stage AKI (creatinine value 1.5 times OR creatinine value\> 0.3 initial OR urine production \<0.5 ml/kg/hour for 6-12 hours * Patients, both men and women, in the age range of 18 - 60 years * Patients who experience post clean operative sepsis * Patients who agree to attend the study by signing informed consent Exclusion Criteria: * Patients with primary heart problems, right or heart failure suffer from congenital heart disease * Have severe chronic obstructive pulmonary disease, patients with severe pleural effusion * Patients who, based on ultrasound examination, found stones or tumors in the kidney during the study period * CKD patients are based on history taking and physical examination * DNR (do not resuscitate) patients

What they're measuring

Capillary Perfusion Density

Timeframe: 7 days

Trial details

NCT IDNCT04156451

SponsorIndonesia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-09-30

View on ClinicalTrials.gov More Septic Shock trials